Medpage Today on MSN
WIC Telehealth Program Improved Diet, Had Modest Impact on Weight Gain in Pregnancy
Recommendations for optimal gestational weight gain are different depending on a woman's body mass index (BMI), ranging from ...
By JESSICA DAMIANO There are gifts, and then there are gifts, the ones inventive enough to surprise and delight the recipient. Some are fun; others, practical. They all aim to improve how we do or ...
Good morning, ladies and gentlemen, and welcome to the Fidelis Insurance Group's Third Quarter 2025 Earnings Conference Call. [Operator Instructions] With that, I will now turn the call over to ...
Onyx Gold Corp. is a Canadian exploration company focused on unlocking district-scale gold opportunities in two of the ...
Continued advancement toward Phase 2/3 clinical trial initiation, on track for the first half of 2026New preclinical data demonstrated SIL204’s ...
Make no mistake, Saturday might be the biggest BYU football game in 40 years. When BYU takes the field against #7 Texas Tech, it will the first meeting between ...
Continued advancement toward Phase 2/3 clinical trial initiation, on track for the first half of 2026 New preclinical data demonstrated SIL204's exceptional efficacy across multiple human cancer cell ...
Everyday Health on MSN
Experimental Obesity Drug Could Soon Compete With Wegovy and Zepbound
Drugmaker Eli Lilly said it would soon start late-stage trials for eloralintide, a drug mimicking the pancreatic hormone amylin that slows digestion and reduces hunger.
The dairy industry and everyone else remains in a government shutdown cloud as October comes to an end, appropriately on ...
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage ...
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results